Copyright
©The Author(s) 2004.
World J Gastroenterol. Dec 1, 2004; 10(23): 3506-3510
Published online Dec 1, 2004. doi: 10.3748/wjg.v10.i23.3506
Published online Dec 1, 2004. doi: 10.3748/wjg.v10.i23.3506
Table 1 Baseline clinical characteristics of patients
| Factor | Group A (n = 14) | Group B (n = 20) | P |
| Mean age (yr) | 57.9 ± 9.2 | 63.3 ± 11.4 | 0.356 |
| Gender | |||
| Male | 8 | 10 | 0.681 |
| Female | 6 | 10 | |
| Mean total serum bilirubin | 318 ± 94 | 314 ± 115 | 0.913 |
| concentration (μmol/L) | |||
| Mean alanine | 71 ± 52 | 106 ± 107 | 0.261 |
| aminotransferase concentration (U/L) | |||
| Mean albumin | 33.6 ± 4.3 | 33.5 ± 3.4 | 0.914 |
| concentration (g/L) | |||
| Mean alkaline | 443 ± 334 | 543 ± 400 | 0.449 |
| phosphatase (U/L) | |||
| Mean hemoglobin | 111 ± 12 | 105 ± 16 | 0.275 |
| concentration (g/L) | |||
| Mean obstructive | 3.7 ± 0.9 | 4.0 ± 1.4 | 0.512 |
| duration (wk) | |||
| Obstructive level | |||
| Hilar | 8 | 12 | 0.868 |
| Common bile duct | 6 | 8 | |
| TACE | |||
| Performed | 9 | 10 | 0.409 |
| Not performed | 5 | 10 |
- Citation: Chen Y, Wang XL, Yan ZP, Cheng JM, Wang JH, Gong GQ, Qian S, Luo JJ, Liu QX. HDR-192Ir intraluminal brachytherapy in treatment of malignant obstructive jaundice. World J Gastroenterol 2004; 10(23): 3506-3510
- URL: https://www.wjgnet.com/1007-9327/full/v10/i23/3506.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i23.3506